Narrow search
Showing 1 - 10 of 280,853
Cover Image
Behind the Scenes : Sources of Complementarity in R&D
Ceccagnoli, Marco - 2014
investments through the structural estimation of a flexible innovation production function, such as the translog. Our empirical …
Persistent link: https://www.econbiz.de/10013064588
Cover Image
Behind the scenes : sources of complementarity in R&D
Ceccagnoli, Marco; Higgins, Matthew J.; Palermo, Vincenzo - 2013
Persistent link: https://www.econbiz.de/10009722826
Cover Image
Behind the Scenes : Sources of Complementarity in R&D
Ceccagnoli, Marco - 2013
investments through the structural estimation of a flexible innovation production function, such as the translog. Our empirical …
Persistent link: https://www.econbiz.de/10012459867
Cover Image
Productivity and heterogeneous knowledge : exploring the relationship in a sample of drug developers
Bottazzi, Giulio; Plotnikova, Tatiana - 2010
This paper aims to investigate the effect of knowledge characteristics on the total factor productivity of firms developing drugs in the pharmaceutical industry. We decompose knowledge into knowledge associated with the technological firm portfolio and knowledge related to R&D projects, which...
Persistent link: https://www.econbiz.de/10003989032
Cover Image
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Correa, Carlos María - 2020
Persistent link: https://www.econbiz.de/10012433977
Cover Image
Compulsory licensing as a remedy against excessive pricing of life-saving medicines
Kianzad, Behrang - 2024
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
Cover Image
Multinational firms and global innovation
Gumpert, Anna; Manova, Kalina; Rujan, Cristina; … - 2025
This paper provides an integrated analysis of multinational companies’ global production and innovation. We establish … of production, basic innovation and applied innovation, under asymmetric complementarities across these three activities … and quality, and offshore innovation to more countries, including both countries with and without production affiliates …
Persistent link: https://www.econbiz.de/10015326180
Cover Image
Impact of big pharma organizational structure on R & D productivity
Held, Sebastian (contributor) - 2009
Persistent link: https://www.econbiz.de/10003889567
Cover Image
The impact of stronger property rights in pharmaceuticals on innovation in developed and developing countries
Liu, Ming; La Croix, Sumner J. - 2011
Persistent link: https://www.econbiz.de/10009503531
Cover Image
The impact of stronger property rights in pharmaceuticals on innovation in developed and developing countries
Liu, Ming; La Croix, Sumner J. - 2014
Persistent link: https://www.econbiz.de/10010378908